Epidemiology Study of Keloid

Keloid Clinical Trial

Official title:

Epidemiology Study of Keloid

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01423383
• Other study ID #: Tirgan 11-04
• Status: Recruiting
• Phase: N/A
• First received: August 23, 2011
• Last updated: October 17, 2016
• Start date: September 2011
• Est. completion date: December 2021

Study information

• Verified date: October 2016
• Source: Tirgan, Michael H., M.D.
• Contact: Michael H. Tirgan, MD
• Phone: (212) 874 4200
• Email: htirgan[@]aol.com
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Although keloid is a very common condition; there are no statistics as to its true incidence and prevalence, neither in United States, nor elsewhere in the world. This trial intends to capture epidemiological data about this disease in a large population sample.

Description:

The purpose of current trial is to establish a robust database of incidence and prevalence of keloid, as well as prevalence of familial keloid, in various ethnic groups. Study sample size is 100,000 random individuals who will fill out either a web survery or a paper questionnaire.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100000
• Est. completion date: December 2021
• Est. primary completion date: June 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

1. Informed consent

2. Age above 18 to answer the survey questions

3. Parents shall respond on behalf of their minor children

Exclusion Criteria:

Study Design

Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Keloid

Locations

Country	Name	City	State
United States	Michael H. Tirgan, MD	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Tirgan, Michael H., M.D.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of various clinical findings will be determined at the end of Survey.	This will be a prospective online and paper based survey with an estimated 100,000 responders participating in two years. Statistics will be descriptive. The prevalence of various clinical findings will be determined at the end of Survey. Findings will be correlated with the source of the data, online, or paper questionnaire, as well as the locations where the paper questionnaires surveys were placed.	Two Years	No

External Links

•   This is the official website of this study.